Clinical recognition and management of tularemia in Missouri: A retrospective records review of 121 cases

Clinical Infectious Diseases

Volumn 55, Issue 10, 2012, Pages 1283-1290

  Weber, Ingrid B ^a,b   Turabelidze, George ^c   Patrick, Sarah ^c   Griffith, Kevin S ^b   Kugeler, Kiersten J ^b   Mead, Paul S ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; LEVOFLOXACIN; STREPTOMYCIN; TETRACYCLINE DERIVATIVE;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMAN; INCUBATION TIME; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; TICK BITE; TULAREMIA; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTI-BACTERIAL AGENTS; ARACHNID VECTORS; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MISSOURI; RETROSPECTIVE STUDIES; TICKS; TULAREMIA;

EID: 84868026122     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis706     Document Type: Review

References (26)

1. Francis E. A summary of present knowledge of tularaemia. Medicine 1927; VII:411-32.
2. Tarnvik A, Chu MC. New approaches to diagnosis and therapy of tularemia. Ann N Y Acad Sci 2007; 1105:378-404.
3. Overholt EL, Tigertt WD, Kadull PJ, et al. An analysis of forty-two cases of laboratory-acquired tularemia. Treatment with broad spectrum antibiotics. Am J Med 1961; 30:785-806.
4. Penn RL, Kinasewitz GT. Factors associated with a poor outcome in tularemia. Arch Intern Med 1987; 147:265-8.
5. Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA 2001; 285:2763-73.
6. Centers for Disease Control and Prevention. Recognition of illness associated with the intentional release of a biologic agent. (Reprinted from MMWR 2001; 50:893.) JAMA 2001; 286:2088-90.
7. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 2002; 8:225-30.
8. Enderlin G, Morales L, Jacobs RF, Cross JT. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin Infect Dis 1994; 19:42-7.
9. Pagkalis S, Mantadakis E, Mavros MN, Ammari C, Falagas ME. Pharmacological considerations for the proper clinical use of aminoglycosides. Drugs 2011; 71:2277-94.
10. Urich SK, Petersen JM. In vitro susceptibility of isolates of Francisella tularensis types A and B from North America. Antimicrob Agents Chemother 2008; 52:2276-8.
11. Johansson A, Berglund L, Sjostedt A, Tarnvik A. Ciprofloxacin for treatment of tularemia. Clin Infect Dis 2001; 33:267-8.
12. Limaye AP, Hooper CJ. Treatment of tularemia with fluoroquinolones: two cases and review. Clin Infect Dis 1999; 29:922-4.
13. Centers for Disease Control and Prevention. Tularemia-United States, 1990-2000. MMWR Morb Mortal Wkly Rep 2002; 51:182-4.
14. Centers for Disease Control and Prevention. Tularemia-Missouri, 2000-2007. MMWR Morb Mortal Wkly Rep 2009; 58:744-8.
15. Taylor JP, Istre GR, McChesney TC, Satalowich FT, Parker RL, McFarland LM. Epidemiologic characteristics of human tularemia in the southwest-central states, 1981-1987. Am J Epidemiol 1991; 133: 1032-8.
16. Pullen RL SB. Tularemia: analysis of 225 cases. JAMA 1945; 129: 495-500.
17. Assal N, Blenden DC, Price ER. Epidemiologic study of human tularemia reported in Missouri, 1949-65. Public Health Rep 1967; 82: 627-32.
18. Bisno AL, Gerber MA, Gwaltney JM Jr., Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 2002; 35:113-25.
19. Arav-Boger R. Cat-bite tularemia in a seventeen-year-old girl treated with ciprofloxacin. Pediatr Infect Dis J 2000; 19:583-4.
20. Scheftel JM, Griffith JM, Leppke BA, Pantlin GC, Snippes PM, Wunschmann A. Tularaemia in Minnesota: case report and brief epidemiology. Zoonoses Public Health, 2010; 57:e165-9.
21. Reynolds MG, Holman RC, Curns AT, O'Reilly M, McQuiston JH, Steiner CA. Epidemiology of cat-scratch disease hospitalizations among children in the United States. Pediatr Infect Dis J 2005; 24:700-4.
22. Snowden J, Stovall S. Tularemia: retrospective review of 10 years' experience in Arkansas. Clin Pediatr (Phila) 2011; 50:64-8.
23. Kugeler KJ, Mead PS, Janusz AM, et al. Molecular epidemiology of Francisella tularensis in the United States. Clin Infect Dis 2009; 48:863-70.
24. Staples JE, Kubota KA, Chalcraft LG, Mead PS, Petersen JM. Epidemiologic and molecular analysis of human tularemia, United States, 1964-2004. Emerg Infect Dis 2006; 12:1113-8.
25. Nakazawa Y, Williams RA, Peterson AT, Mead PS, Kugeler KJ, Petersen JM. Ecological niche modeling of Francisella tularensis subspecies and clades in the United States. Am J Trop Med Hyg 2010; 82:912-8.
26. Sanchez Garcia M. Early antibiotic treatment failure. Int J Antimicrob Agents 2009; 34(suppl 3):S14-9.